chr9-126693123-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001174147.2(LMX1B):c.560-19C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00324 in 1,554,862 control chromosomes in the GnomAD database, including 29 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0069 ( 7 hom., cov: 34)
Exomes 𝑓: 0.0028 ( 22 hom. )
Consequence
LMX1B
NM_001174147.2 intron
NM_001174147.2 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.85
Genes affected
LMX1B (HGNC:6654): (LIM homeobox transcription factor 1 beta) This gene encodes a member of LIM-homeodomain family of proteins containing two N-terminal zinc-binding LIM domains, 1 homeodomain, and a C-terminal glutamine-rich domain. It functions as a transcription factor, and is essential for the normal development of dorsal limb structures, the glomerular basement membrane, the anterior segment of the eye, and dopaminergic and serotonergic neurons. Mutations in this gene are associated with nail-patella syndrome. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 9-126693123-C-T is Benign according to our data. Variant chr9-126693123-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 258628.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-126693123-C-T is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00692 (1054/152326) while in subpopulation AFR AF= 0.0162 (674/41576). AF 95% confidence interval is 0.0152. There are 7 homozygotes in gnomad4. There are 458 alleles in male gnomad4 subpopulation. Median coverage is 34. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1054 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LMX1B | NM_001174147.2 | c.560-19C>T | intron_variant | ENST00000373474.9 | |||
LMX1B | NM_001174146.2 | c.560-19C>T | intron_variant | ||||
LMX1B | NM_002316.4 | c.560-19C>T | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LMX1B | ENST00000373474.9 | c.560-19C>T | intron_variant | 1 | NM_001174147.2 | P4 | |||
LMX1B | ENST00000355497.10 | c.560-19C>T | intron_variant | 1 | |||||
LMX1B | ENST00000526117.6 | c.560-19C>T | intron_variant | 1 | A1 |
Frequencies
GnomAD3 genomes AF: 0.00692 AC: 1053AN: 152208Hom.: 7 Cov.: 34
GnomAD3 genomes
AF:
AC:
1053
AN:
152208
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00356 AC: 578AN: 162334Hom.: 4 AF XY: 0.00314 AC XY: 271AN XY: 86394
GnomAD3 exomes
AF:
AC:
578
AN:
162334
Hom.:
AF XY:
AC XY:
271
AN XY:
86394
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00284 AC: 3984AN: 1402536Hom.: 22 Cov.: 32 AF XY: 0.00287 AC XY: 1989AN XY: 692124
GnomAD4 exome
AF:
AC:
3984
AN:
1402536
Hom.:
Cov.:
32
AF XY:
AC XY:
1989
AN XY:
692124
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00692 AC: 1054AN: 152326Hom.: 7 Cov.: 34 AF XY: 0.00615 AC XY: 458AN XY: 74476
GnomAD4 genome
AF:
AC:
1054
AN:
152326
Hom.:
Cov.:
34
AF XY:
AC XY:
458
AN XY:
74476
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
4
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 26, 2019 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at